BPA Call 36C24820A0022-36C24820N0737
Award Date 7/22/20
Potential Completion Date 8/31/20
Potential Value $136K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a Blanket Purchase Agreement (BPA) Call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB) for an estimated $136,409.05. The BPA Call has a completion date of October 24, 2020 and was awarded on August 20, 2020 under firm fixed pricing terms. Place of performance will be in King of Prussia, Pennsylvania. No set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded CSL Behring L.L.C. a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The BPA call has a potential value of $25,213.77 and requires delivery of unspecified pharmaceutical or drug products to locations in King of Prussia, Pennsylvania under firm fixed price terms by April 30, 2020. No set-aside designation...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a $117,050.64 potential value blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB). The BPA, described as a VISN WIDE BPA with no set-aside designation, is for the delivery of pharmaceutical products and has a completion date of August 20, 2020. Performance will take place in King of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule to CSL Behring L.L.C. for an estimated $136,441.88. The BPA, titled "VISN WIDE BPA," has a completion date of May 25, 2020 and was awarded on May 20, 2020. It utilizes firm fixed pricing and has no set-aside designation. The BPA was issued under the VHA's network-wide...
- CSL Behring L.L.C. was awarded a blanket purchase agreement (BPA) call contract valued at one hundred seventeen thousand fifty dollars and sixty-four cents ($117,050.64) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract was awarded on December 22, 2020 under the Pharmaceuticals and Drugs Federal Supply Schedule with a completion date of December 31, 2020. It utilizes firm fixed pricing and has no set-aside designation. The...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $77,625.80, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The awarded BPA call is for...
- This Blanket Purchase Agreement (BPA) call was awarded under the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 8's (VISN 8) master GSA Schedule contract for pharmaceuticals and drugs. CSL Behring L.L.C. will deliver $25,227.62 worth of Privigen 675A00060, a human plasma-derived intravenous immunoglobulin product, on a firm fixed price basis to locations in King of Prussia, Pennsylvania. No set-aside designation was applied to this BPA call issued under the VA's...
- This federal contract award is for the procurement of various specialty pharmaceutical products by the U.S. Department of Veterans Affairs (VA) from CSL Behring L.L.C., a global biotherapeutics company. The award, valued at $99,203.50, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The products being delivered include CARIMUNE (immune globulin), PRIVIGEN (immune globulin), and THROMBIN,...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The contract is for the supply of 5 gram vials of the immune globulin drug Privigen. The BPA call has a ceiling value of $84,903.00 and was awarded under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of...
- This federal contract award was issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The $87,734.72 firm fixed-price delivery order is for the provision of blood clotting medication to VA medical facilities. The contract is not set aside and is issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for...